# Corticosteroids as adjunctive therapy in patients with acute/subacute paracoccidioidomycosis presenting a severe paradoxical inflammatory reaction: Two case reports and literature review

**Authors:** Pedro Stringelli-Brandão, Marília Prior Fuga, Márcio Ketner Sguassábia, Ivonete Helena Rocha, Mario León Silva-Vergara

PMC · DOI: 10.1016/j.bjid.2025.104608 · The Brazilian Journal of Infectious Diseases · 2026-01-13

## TL;DR

Two patients with a fungal infection got worse after treatment but improved with corticosteroids, suggesting steroids may help in similar cases.

## Contribution

This paper reports two new cases where corticosteroids improved severe inflammatory reactions in paracoccidioidomycosis patients.

## Key findings

- Two PCM patients worsened after antifungal therapy but improved with corticosteroids.
- Exclusion of other infections confirmed the inflammatory reaction was specific to PCM treatment.
- Corticosteroids were tapered after 2-3 weeks with continued outpatient care.

## Abstract

Paradoxical inflammatory reactions, similar to Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV, have been occasionally reported in leprosy, tuberculosis, certain immunosuppressive conditions, and Paracoccidioidomycosis (PCM), among others. This report presents the clinical data and outcomes of two PCM cases in which the patients developed a severe inflammatory reaction following antifungal therapy, with subsequent improvement after adjunctive corticosteroid use. Both patients were adults with acute/subacute PCM who experienced clinical worsening after starting liposomal amphotericin B, with fever, anasarca, jaundice, and exacerbation of pre-existing symptoms. After excluding other infections, intravenous hydrocortisone was administered, resulting in rapid improvement. Corticosteroids were tapered after two to three weeks, and both patients continued outpatient follow-up while receiving itraconazole. Few similar PCM cases have been described in the literature, and they reported comparable outcomes. Its exact mechanism remains unclear, but may be immune-mediated. Reporting additional cases is essential to better establish the true incidence of this reaction and to strengthen the evidence supporting the benefit of corticosteroids as an adjunctive therapy.

## Linked entities

- **Chemicals:** liposomal amphotericin B (PubChem CID 44405442), hydrocortisone (PubChem CID 5754), itraconazole (PubChem CID 55283)
- **Diseases:** paracoccidioidomycosis (MONDO:0005894), Immune Reconstitution Inflammatory Syndrome (MONDO:0100185), leprosy (MONDO:0005124), tuberculosis (MONDO:0018076)

## Full-text entities

- **Diseases:** anasarca (MESH:D004487), inflammatory (MESH:D007249), fever (MESH:D005334), PCM (MESH:D010229), jaundice (MESH:D007565), IRIS (MESH:D054019), infections (MESH:D007239), tuberculosis (MESH:D014376), leprosy (MESH:D007918), HIV (MESH:D015658)
- **Chemicals:** amphotericin B (MESH:D000666), hydrocortisone (MESH:D006854), itraconazole (MESH:D017964)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12830142/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12830142/full.md

---
Source: https://tomesphere.com/paper/PMC12830142